Eidos Therapeutics, Inc. — key financial figures for fiscal year 2019 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2019)

$26.7M

Net Income/Loss (FY2019)

-$37.8M

Total Assets (FY2019)

$203.8M

Total Equity (FY2019)

$171.4M

Cash Flows from Operating Activities (FY2019)

-$31.6M

Source: Eidos Therapeutics, Inc. 10-K filing (FY2019). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.